Contact
searchSearch
HMP Global

September 2013 - FRMC

Fulyzaq™ (crofelemer) - Oral Therapy Approved to Relieve Diarrhea in Patients with HIV/AIDS
09/19/2013
The FDA approved Fulyzaq™ (crofelemer) in December 2012 to relieve noninfectious diarrhea in adults with HIV or AIDS who are taking anti-retroviral therapy.
The FDA approved Fulyzaq™ (crofelemer) in December 2012 to relieve noninfectious diarrhea in adults with HIV or AIDS who are taking anti-retroviral therapy.
The FDA approved Fulyzaq™...
09/19/2013
First Report Managed Care
Functional Impact of Adverse Events Associated with Pain Medications
09/19/2013
Tim Casey
Two phase 3 trials found that patients with moderate-to-severe chronic low back pain or osteoarthritis of the knee who experienced adverse events during the studies had problems associated with physical functioning, social functioning, mental...
Two phase 3 trials found that patients with moderate-to-severe chronic low back pain or osteoarthritis of the knee who experienced adverse events during the studies had problems associated with physical functioning, social functioning, mental...
Two phase 3 trials found that...
09/19/2013
First Report Managed Care
Hydromorphone Extended Release for Chronic Pain
09/19/2013
Tim Casey
In clinical practice, patients with moderate-to-severe chronic pain received doses of hydromorphone extended release that were nearly 50% lower than the doses given to patients who were prescribed oxymorphone extended release or oxycodone...
In clinical practice, patients with moderate-to-severe chronic pain received doses of hydromorphone extended release that were nearly 50% lower than the doses given to patients who were prescribed oxymorphone extended release or oxycodone...
In clinical practice, patients...
09/19/2013
First Report Managed Care
Abuse and Misuse of Opioid Medications
09/19/2013
Tim Casey
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been...
09/19/2013
First Report Managed Care
Phase 3 Trial of Cariprazine for Schizophrenia
09/19/2013
Tim Casey
San Francisco—After 9 weeks of treatment, patients with schizophrenia who received 3 mg or 6 mg of cariprazine had significant improvements in Positive and Negative Syndrome Scale (PANSS) total score and Clinical Global Impressions-Severity...
San Francisco—After 9 weeks of treatment, patients with schizophrenia who received 3 mg or 6 mg of cariprazine had significant improvements in Positive and Negative Syndrome Scale (PANSS) total score and Clinical Global Impressions-Severity...
San Francisco—After 9 weeks of...
09/19/2013
First Report Managed Care
Follow-Up Visits after Hospital Discharge for Schizophrenia
09/19/2013
Tim Casey
San Francisco—Within 30 days of hospital discharge, approximately one third of patients with schizophrenia who had Medicaid or private health insurance failed to have a follow-up visit, according to a retrospective, longitudinal cohort...
San Francisco—Within 30 days of hospital discharge, approximately one third of patients with schizophrenia who had Medicaid or private health insurance failed to have a follow-up visit, according to a retrospective, longitudinal cohort...
San Francisco—Within 30 days of...
09/19/2013
First Report Managed Care
Reduction in MADRS Total Score for Patients with MDD
09/19/2013
Tim Casey
San Francisco—After 8 weeks of treatment, patients with major depressive disorder (MDD) who received 20 mg of vortioxetine had a significant reduction in Montgomery-Asberg Depression Rating Scale (MADRS) total score compared with patients who...
San Francisco—After 8 weeks of treatment, patients with major depressive disorder (MDD) who received 20 mg of vortioxetine had a significant reduction in Montgomery-Asberg Depression Rating Scale (MADRS) total score compared with patients who...
San Francisco—After 8 weeks of...
09/19/2013
First Report Managed Care
Improving Rates of Functional Response in Major Depressive Disorder
09/19/2013
Tim Casey
San Francisco—Patients with major depressive disorder who received 80 mg or 120 mg of levomilnacipran sustained release had significant functional improvement and greater rates of functional response compared with a placebo group, according...
San Francisco—Patients with major depressive disorder who received 80 mg or 120 mg of levomilnacipran sustained release had significant functional improvement and greater rates of functional response compared with a placebo group, according...
San Francisco—Patients with...
09/19/2013
First Report Managed Care
News Connection
Enrollment in Medicare Part D Subsidy Program and Cognition Skills
09/19/2013
Tori Socha
Beneficiaries enrolled in Medicare Part D with limited income and resources are eligible for a low-income subsidy (LIS) cost-sharing and premium assistance.
Beneficiaries enrolled in Medicare Part D with limited income and resources are eligible for a low-income subsidy (LIS) cost-sharing and premium assistance.
Beneficiaries enrolled in...
09/19/2013
First Report Managed Care
News Connection
Health Status of Uninsured Adults with Potential Medicaid Eligibility under ACA
09/19/2013
Tori Socha
In states that choose to expand Medicaid under provisions in the Patient Protection and Affordable Care Act (ACA), the program’s focus will shift from low-income pregnant women and children, very–low-income parents, and severely disabled to...
In states that choose to expand Medicaid under provisions in the Patient Protection and Affordable Care Act (ACA), the program’s focus will shift from low-income pregnant women and children, very–low-income parents, and severely disabled to...
In states that choose to expand...
09/19/2013
First Report Managed Care
News Connection
Patients with Observation Status
09/19/2013
Tori Socha
The use of hospitalizations with observation status has increased for Medicare beneficiaries; while inpatient stays decreased.
The use of hospitalizations with observation status has increased for Medicare beneficiaries; while inpatient stays decreased.
The use of hospitalizations with...
09/19/2013
First Report Managed Care
News Connection
Clinical Guidance Documents and Cost Considerations
09/19/2013
Tori Socha
The need to control healthcare costs is widely acknowledged, but questions remain about who should take responsibility for reining in healthcare-associated spending.
The need to control healthcare costs is widely acknowledged, but questions remain about who should take responsibility for reining in healthcare-associated spending.
The need to control healthcare...
09/19/2013
First Report Managed Care
News Connection
Predicting Overall Hospital Mortality Rates
09/19/2013
Tori Socha
One strategy for improving the quality of care in hospitals in the United States is public reporting of hospital performance.
One strategy for improving the quality of care in hospitals in the United States is public reporting of hospital performance.
One strategy for improving the...
09/19/2013
First Report Managed Care
Symptom Burden in Metastatic Breast Cancer
09/19/2013
Tori Socha
In 2012, approximately 39,510 women in the United States died of breast cancer. First-line treatment of metastatic breast cancer (MBC) yielded median survival of 20.5 months in recent phase 3 trials. The majority of patients develop MBC...
In 2012, approximately 39,510 women in the United States died of breast cancer. First-line treatment of metastatic breast cancer (MBC) yielded median survival of 20.5 months in recent phase 3 trials. The majority of patients develop MBC...
In 2012, approximately 39,510...
09/19/2013
First Report Managed Care
Study Identifies Molecular Mechanisms of Uterine Leiomyomas
09/19/2013
Eileen Koutnik-Fotopoulos
New data demonstrated that multiple separate tumors could be seeded from a single lineage of uterine leiomyoma cells. Based on the results, an accurate molecular classification of uterine leiomyomas is emerging. Identifying the potential...
New data demonstrated that multiple separate tumors could be seeded from a single lineage of uterine leiomyoma cells. Based on the results, an accurate molecular classification of uterine leiomyomas is emerging. Identifying the potential...
New data demonstrated that...
09/19/2013
First Report Managed Care
News Connection
Racial Disparities in Survival in Breast Cancer
09/19/2013
Tori Socha
Healthcare researchers have identified racial disparities in survival among women with breast cancer for the past 20 years. Studies have demonstrated worse outcomes in black patients with breast cancer and have identified possible reasons for...
Healthcare researchers have identified racial disparities in survival among women with breast cancer for the past 20 years. Studies have demonstrated worse outcomes in black patients with breast cancer and have identified possible reasons for...
Healthcare researchers have...
09/19/2013
First Report Managed Care
News Connection
Breast Cancer Outcomes May Be Impacted by Treatment Setting
09/19/2013
Tori Socha
  Trastuzumab-based therapies are recommended by the National Comprehensive Cancer Network for the treatment of HER2-positive (HER2+) metastatic breast cancer. In HER+ breast cancer patients, trastuzumab, administered via intravenous...
  Trastuzumab-based therapies are recommended by the National Comprehensive Cancer Network for the treatment of HER2-positive (HER2+) metastatic breast cancer. In HER+ breast cancer patients, trastuzumab, administered via intravenous...
  Trastuzumab-based therapies...
09/19/2013
First Report Managed Care
Breast Density and Screening Mammography Outcomes
09/19/2013
Tori Socha
Prior to 2009, the US Preventive Services Task Force guidelines recommended that women 50 to 74 years of age receive a screening mammogram every 1 to 2 years. In 2009, the task force revised those guidelines, calling for biennial mammography...
Prior to 2009, the US Preventive Services Task Force guidelines recommended that women 50 to 74 years of age receive a screening mammogram every 1 to 2 years. In 2009, the task force revised those guidelines, calling for biennial mammography...
Prior to 2009, the US Preventive...
09/19/2013
First Report Managed Care
Pneumonia Vaccine Reduces US Hospitalizations
09/19/2013
Eileen Koutnik-Fotopoulos
A new study found that annual hospitalization rates for pneumonia had fallen since the 2000 introduction of the 7-valent pneumococcal conjugate vaccine, regardless of immunization status, by an age-adjusted reduction of 54.8 per 100,000. 
A new study found that annual hospitalization rates for pneumonia had fallen since the 2000 introduction of the 7-valent pneumococcal conjugate vaccine, regardless of immunization status, by an age-adjusted reduction of 54.8 per 100,000. 
A new study found that annual...
09/19/2013
First Report Managed Care
News Connection
Acute Care Spending in High-Cost Medicare Population
09/19/2013
Tori Socha
Previous studies have shown that Medicare spending is highly concentrated; 10% of the Medicare population accounts for >50% of the costs of the program. The largest share of spending among high-cost Medicare beneficiaries is related to...
Previous studies have shown that Medicare spending is highly concentrated; 10% of the Medicare population accounts for >50% of the costs of the program. The largest share of spending among high-cost Medicare beneficiaries is related to...
Previous studies have shown that...
09/19/2013
First Report Managed Care
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
09/19/2013
Kevin L. Carter
When all-trans retinoic acid (ATRA) is used with chemotherapy as the standard of care for acute promyelocytic leukemia (APL), remission rates can reach 95%, and cure rates typically exceed 80%. Arsenic trioxide with or without ATRA has also...
When all-trans retinoic acid (ATRA) is used with chemotherapy as the standard of care for acute promyelocytic leukemia (APL), remission rates can reach 95%, and cure rates typically exceed 80%. Arsenic trioxide with or without ATRA has also...
When all-trans retinoic acid...
09/19/2013
First Report Managed Care
Treatment of Nonmelanoma Skin Cancer at End of Life
09/19/2013
Tori Socha
Healthcare providers, particularly those treating a population of geriatric patients, may face the challenge of determining appropriate care of nonfatal conditions for patients with limited life expectancy (LLE). A study of Medicare...
Healthcare providers, particularly those treating a population of geriatric patients, may face the challenge of determining appropriate care of nonfatal conditions for patients with limited life expectancy (LLE). A study of Medicare...
Healthcare providers,...
09/19/2013
First Report Managed Care
Risk of Exacerbations in COPD Associated with Inflammatory Biomarkers
09/19/2013
Tori Socha
Patients with chronic obstructive pulmonary disease (COPD) who experience exacerbations of respiratory symptoms may have lasting adverse effects. Frequent episodes of COPD exacerbations may accelerate loss of lung function, affect quality of...
Patients with chronic obstructive pulmonary disease (COPD) who experience exacerbations of respiratory symptoms may have lasting adverse effects. Frequent episodes of COPD exacerbations may accelerate loss of lung function, affect quality of...
Patients with chronic...
09/19/2013
First Report Managed Care
Advanced Treatment Options for Men with Low-Risk Prostate Cancer
09/19/2013
Mary Beth Nierengarten
Results of a retrospective cohort study show that the use of advanced treatment technologies for men with prostate cancer with low-risk disease, those at high risk of noncancer mortality, or men with both low-risk disease and at high risk of...
Results of a retrospective cohort study show that the use of advanced treatment technologies for men with prostate cancer with low-risk disease, those at high risk of noncancer mortality, or men with both low-risk disease and at high risk of...
Results of a retrospective...
09/19/2013
First Report Managed Care
News Connection
Prescribing Broad-Spectrum Antibiotics by Pediatricians
09/19/2013
Tori Socha
The most common prescription drugs given to children are antibiotics, and the vast majority of these prescriptions are prescribed in the outpatient setting. Approximately 75% of pediatric antibiotic prescriptions are written to treat acute...
The most common prescription drugs given to children are antibiotics, and the vast majority of these prescriptions are prescribed in the outpatient setting. Approximately 75% of pediatric antibiotic prescriptions are written to treat acute...
The most common prescription...
09/19/2013
First Report Managed Care
News Connection
ACE Unit Model Reduces Costs and 30-Day Readmissions
09/19/2013
Tori Socha
By 2030, 20% of the US population will be at least 65 years of age, creating an increased burden on the healthcare system. Delivering high-quality care while controlling costs includes strategies for improving patient outcomes, particularly...
By 2030, 20% of the US population will be at least 65 years of age, creating an increased burden on the healthcare system. Delivering high-quality care while controlling costs includes strategies for improving patient outcomes, particularly...
By 2030, 20% of the US...
09/19/2013
First Report Managed Care
News Connection
Treatment for Patients with Post-ACS Depression
09/19/2013
Tori Socha
Depression, becoming the leading cause of years living with disability worldwide, is particularly burdensome when comorbid with a chronic medical disorder. In the United States, 1.2 million patients survive an acute coronary syndrome (ACS)...
Depression, becoming the leading cause of years living with disability worldwide, is particularly burdensome when comorbid with a chronic medical disorder. In the United States, 1.2 million patients survive an acute coronary syndrome (ACS)...
Depression, becoming the leading...
09/19/2013
First Report Managed Care
News Connection
Live MMR Booster Vaccination in Patients with JIA
09/19/2013
Tori Socha
Children worldwide receive the live attenuated measles-mumps-rubella (MMR) vaccine via national immunization programs (NIPs).
Children worldwide receive the live attenuated measles-mumps-rubella (MMR) vaccine via national immunization programs (NIPs).
Children worldwide receive the...
09/19/2013
First Report Managed Care
Conference Insider
Rates of Cardiac Catheterization in Ontario and New York State
09/19/2013
Tori Socha
A recent study found that only 1 in 3 patients in the United States who received electric cardiac catheterization had obstructive coronary artery disease (CAD), raising concerns about the necessity of cardiac procedures for patients with...
A recent study found that only 1 in 3 patients in the United States who received electric cardiac catheterization had obstructive coronary artery disease (CAD), raising concerns about the necessity of cardiac procedures for patients with...
A recent study found that only 1...
09/19/2013
First Report Managed Care
News Connection
Kaiser: Transitioning Medicaid Population to Mandatory Managed Care
09/19/2013
Jill Sederstorm
A new study examining California's shift to mandatory managed care for Medicaid beneficiaries with complex care needs found that adequate time and planning to minimize the disruption of care are essential to a successful transition.
A new study examining California's shift to mandatory managed care for Medicaid beneficiaries with complex care needs found that adequate time and planning to minimize the disruption of care are essential to a successful transition.
A new study examining...
09/19/2013
First Report Managed Care
Kaiser Report: Moderate Premium Increases in 2013
09/19/2013
Tim Casey
Starting when the economic conditions worsened significantly in 2009 and continuing throughout the subsequent slow recovery, healthcare cost increases have slowed. Delivery and payment reforms have contributed to the trend, as have people...
Starting when the economic conditions worsened significantly in 2009 and continuing throughout the subsequent slow recovery, healthcare cost increases have slowed. Delivery and payment reforms have contributed to the trend, as have people...
Starting when the economic...
09/19/2013
First Report Managed Care
Conference Insider
Clinton, Sebelius Promote Exchanges, Medicaid Expansion
09/19/2013
Tim Casey
Philadelphia—Six weeks before enrollment began for the new health insurance exchanges, US Department of Health & Human Services (HHS) Secretary Kathleen Sebelius traveled to Pennsylvania to encourage people to sign up for coverage and urge...
Philadelphia—Six weeks before enrollment began for the new health insurance exchanges, US Department of Health & Human Services (HHS) Secretary Kathleen Sebelius traveled to Pennsylvania to encourage people to sign up for coverage and urge...
Philadelphia—Six weeks before...
09/19/2013
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consul...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, h...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
News
Debate Emerges Over FDA's Plan to Regulate Laboratory Medical Tests
05/03/2024
Hannah Musick
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on...
05/03/2024
First Report Managed Care
Interview
Key Pharmaceutical Pipeline Developments: Insights from Industry Experts
05/29/2024
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Learn about promising drugs...
05/29/2024
First Report Managed Care
News
‘Hidden’ Signs May Signal Subclinical Progression in Early MS
07/15/2024
Jolynn Tumolo
Focusing solely on relapse rates and magnetic resonance imaging (MRI) lesion activity to track disease progression in patients with early multiple sclerosis (MS) may miss indicators of subclinical disease activity, with important implications...
Focusing solely on relapse rates and magnetic resonance imaging (MRI) lesion activity to track disease progression in patients with early multiple sclerosis (MS) may miss indicators of subclinical disease activity, with important implications...
Focusing solely on relapse rates...
07/15/2024
First Report Managed Care

September 2013 Volume 10 Issue 9

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use